Dyne

Dyne Therapeutics develops innovative, life-transforming treatments for patients with muscle diseases and other genetically driven conditions.
Domain
Healthcare
Status
IPO’d/​Acquired
IPO Date
2020
Stage of Initial Investment
Series B
Initial Investment Year
2020
Dyne Tx Hover Image